To investigate the potential effect of FGF-1 treatment in diabetes, intravitreal injections of FGF-1 (1.5 μg/2 μL) once per week for one month were administered to treat STZ-induced diabetic rats. This evidence concerns the gene FGF1 and diabetes mellitus.